Transmedics Group Inc (TMDX) Company Profile & Statistics

Transmedics Group Inc
TMDX
(Nasdaq - US)
Closed
79.33
+2.13 (+2.76%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
After Market:79.02-0.31 (-0.39%)
Open
77.21
High
80.89
Low
76.84

About Transmedics Group Inc

CEO

Waleed H. Hassanein

Headquarters

200 minuteman road

andover, ma 01810, united states

Auditor

PricewaterhouseCoopers LLP

Employees

584

Share Holders

Website

www.transmedics.com

Industry

medical specialties

Sector

health technology

Company Overview

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation. TransMedics Inc. is headquartered in Andover, Massachusetts.

Transmedics Group Inc Statistics

Valuation Measures

Market Capitalization ²	2.66B
Enterprise Value	2.84B
Enterprise Value/EBITDA (ttm)	57.81
Price to Earnings Ratio (ttm)	88.21
Price to Book (mrq)	13.26
Price to Sales (ttm)	6.94
Price to Cash (ytd)	582.56

Profitability

Gross Margin (ttm)	59.37%
Operating Margin (ttm)	8.14%
Profit Margin (ttm)	8.03%
Return on Equity (ttm)	18.74%
Return on Invested Capital (ttm)	4.79%
Return on Assets (ttm)	4.39%

Income Statement

Revenue (ttm)	401.09M
Revenue Per Share (ttm)	11.95
Gross Profit (ttm)	237.99M
EBITDA (ttm)³	49.14M
Net Income Avi to Common (ttm)	32.64M
Diluted EPS (ttm)	0.94

Share Statistics

Beta (5Y Monthly)	2.08
52-Week Change	13.59%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	33.56M
Dividend Yield	0.00%
Float ⁴	31.21M
% Held by Insiders	7.00%
% Held by Institutions	99.67%

Balance Sheet

Total Cash (mrq)	330.09M
Total Cash Per Share (mrq)	9.84
Total Debt (mrq)	508.53M
Total Debt/Equity (mrq)	242.25%
Current Ratio (mrq)	8.20%
Quick Ratio (mrq)	7.33%
Book Value Per Share (mrq)	6.25

Cash Flow

Operating Cash Flow Per Share (ytd)	0.82
Free Cash Flow (ytd)	-87.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Transmedics Group Inc

Trade With A Regulated Broker